Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
about
Heat shock proteins as danger signals for cancer detectionHeat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an updateInvestigating citrullinated proteins in tumour cell linesHSP60, a protein downregulated by IGFBP7 in colorectal carcinoma.Human Hsp60 with its mitochondrial import signal occurs in solution as heptamers and tetradecamers remarkably stable over a wide range of concentrations.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinomaAutoantibodies to tumor-associated antigens in breast carcinoma.Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.Exploring the immunoproteome for ovarian cancer biomarker discovery.Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts.Protein biomarkers for the early detection of breast cancer.Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88.An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.Effects of oxygen on the antigenic landscape of prostate cancer cells.Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.Identifying autoantibody signatures in cancer: a promising challenge.Serum autoantibodies as biomarkers for early cancer detection.Integrative oncoproteomics strategies for anticancer drug discovery.Hsp60 chaperonopathies and chaperonotherapy: targets and agents.Profiling of Host Cell Response to Successive Canine Parvovirus Infection Based on Kinetic Proteomic Change Identification.Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis.Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasisIdentification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic ApproachDiscovery of Tamoxifen and N-Desmethyl Tamoxifen Protein Targets in MCF-7 Cells Using Large-Scale Protein Folding and Stability Measurements.Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.Chaperonin of Group I: Oligomeric Spectrum and Biochemical and Biological Implications.Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics.
P2860
Q24273349-E146F5E8-45E8-4545-A9A4-F7BE583D9EB5Q28272905-F2D7BA70-C734-4C41-AD15-CE727CADFE60Q31140984-46F6CEFC-2263-4F97-8F14-7E188F61D8F7Q33569131-5F4FBBBD-AE8B-450A-8A80-EA44F680B98AQ33618484-536DFB01-4804-41DA-A5FF-074115969404Q33895872-5D8F1F23-6843-45F7-B750-B3CAC337154DQ34254009-DF9A05CF-D373-4CB3-9B0E-82415D9AC0F3Q34339160-FDEC2C4D-C227-4723-9A05-1DA0B490DD50Q34347517-59B92C5E-A872-49B4-837C-DAC0F5EAD390Q34578119-F4B9685E-3577-42DB-A133-B9F3C90CE1CEQ35066912-9A6D492C-FBD2-4E59-998C-B5B20558AE27Q35367572-7319A536-9BBB-466F-A31A-FF0468A0B3C4Q35629284-4CA8D8A1-7924-49CC-9A84-68928F792C21Q35680148-EB7C49AD-B66F-4CA6-8C1B-AD5E6A8DBA4AQ35845496-8B1BBFD7-1404-4329-A6A2-9955DE612E61Q36066974-06607D6D-389B-4408-91DA-01295E9B003CQ37579900-AC4C7B86-4C60-4CEC-B701-400935963DBAQ37622471-865B85B8-B5A4-4A06-BCBF-475FB72ECC05Q37763937-8B0D8C2B-94BB-48D2-858D-87AA2105DA0AQ38167037-13DCE7F1-A1FC-4B13-9F5C-244FF7F0AD49Q38444908-803EB20D-C686-40A8-B7E9-E77DF4FAEF88Q38780263-1F18207F-8084-40FD-BEC7-607616B96EB7Q38781970-1AE8FA3D-86A9-4DB0-AE01-948110B2A53AQ38860975-A8846D47-2027-470B-8B59-A29087DA6359Q39298890-52A58CD3-98B6-4DD7-B8C8-C097376C6799Q41660505-05094006-7AD4-4CDB-8D45-CFF31B270B3CQ47777575-871095E2-AFCC-4638-83A1-B707EB92CDF9Q48507661-9A5CDEBA-B946-42C5-8593-3729BC162469Q50104570-82759BF5-E3DA-4892-B473-F8AE8128CDB6Q52558324-68E614EF-CDFE-4FFE-8ED5-E16D76D0D257Q55154018-31961769-35EF-4257-AB3B-AF9E017EDBF3
P2860
Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Proteomics-based identificatio ...... and ductal carcinoma in situ.
@en
Proteomics-based identificatio ...... and ductal carcinoma in situ.
@nl
type
label
Proteomics-based identificatio ...... and ductal carcinoma in situ.
@en
Proteomics-based identificatio ...... and ductal carcinoma in situ.
@nl
prefLabel
Proteomics-based identificatio ...... and ductal carcinoma in situ.
@en
Proteomics-based identificatio ...... and ductal carcinoma in situ.
@nl
P2093
P356
P1476
Proteomics-based identificatio ...... r and ductal carcinoma in situ
@en
P2093
P304
P356
10.1021/PR800130D
P577
2008-08-07T00:00:00Z